
### [NCIT:C7682](http://purl.obolibrary.org/obo/NCIT_C7682)
**Label:** Carcinoma in a Polyp

**Subclasses:** [NCIT:C7678](http://purl.obolibrary.org/obo/NCIT_C7678) (Adenocarcinoma In Situ in Adenomatous Polyp), [NCIT:C4136](http://purl.obolibrary.org/obo/NCIT_C4136) (Adenocarcinoma in Multiple Adenomatous Polyps), [NCIT:C7677](http://purl.obolibrary.org/obo/NCIT_C7677) (Adenocarcinoma in Tubular Adenoma), [NCIT:C7679](http://purl.obolibrary.org/obo/NCIT_C7679) (Adenocarcinoma In Situ in Tubular Adenoma), [NCIT:C7676](http://purl.obolibrary.org/obo/NCIT_C7676) (Adenocarcinoma in Adenomatous Polyp), [NCIT:C4144](http://purl.obolibrary.org/obo/NCIT_C4144) (Adenocarcinoma In Situ in Tubulovillous Adenoma), [NCIT:C4145](http://purl.obolibrary.org/obo/NCIT_C4145) (Adenocarcinoma in Tubulovillous Adenoma), [NCIT:C4134](http://purl.obolibrary.org/obo/NCIT_C4134) (Adenocarcinoma in Adenomatous Polyposis Coli), [NCIT:C7681](http://purl.obolibrary.org/obo/NCIT_C7681) (Carcinoma In Situ in a Polyp), [NCIT:C8376](http://purl.obolibrary.org/obo/NCIT_C8376) (Adenocarcinoma In Situ in Villous Adenoma), [NCIT:C7680](http://purl.obolibrary.org/obo/NCIT_C7680) (Adenocarcinoma In Situ in a Polyp), [NCIT:C4141](http://purl.obolibrary.org/obo/NCIT_C4141) (Adenocarcinoma in Villous Adenoma), 

**Class expressions from DL-Learner:**

- Thing 52.40%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40075](http://purl.obolibrary.org/obo/NCIT_C40075) (Ovarian Endometrioid Cystadenoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40066](http://purl.obolibrary.org/obo/NCIT_C40066) (Undifferentiated Ovarian Sarcoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40063](http://purl.obolibrary.org/obo/NCIT_C40063) (Ovarian Low Grade Endometrioid Stromal Sarcoma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40061](http://purl.obolibrary.org/obo/NCIT_C40061) (Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40043](http://purl.obolibrary.org/obo/NCIT_C40043) (Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40041](http://purl.obolibrary.org/obo/NCIT_C40041) (Ovarian Mucinous Cystadenofibroma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40034](http://purl.obolibrary.org/obo/NCIT_C40034) (Ovarian Mucinous Adenocarcinofibroma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40032](http://purl.obolibrary.org/obo/NCIT_C40032) (Ovarian Serous Cystadenofibroma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40029](http://purl.obolibrary.org/obo/NCIT_C40029) (Borderline Ovarian Serous Cystadenofibroma))) 40.91%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40021](http://purl.obolibrary.org/obo/NCIT_C40021) (Ovarian Lymphoma))) 40.91%


